Cargando…

MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer

Therapy-induced neuroendocrine prostate cancer (NEPC), an extremely aggressive variant of castration-resistant prostate cancer (CRPC), is increasing in incidence with the widespread use of highly potent androgen receptor (AR)-pathway inhibitors (APIs) such as Enzalutamide (ENZ) and Abiraterone and a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhagirath, Divya, Liston, Michael, Patel, Nikhil, Akoto, Theresa, Lui, Byron, Yang, Thao Ly, To, Dat My, Majid, Shahana, Dahiya, Rajvir, Tabatabai, Z Laura, Saini, Sharanjot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7718386/ https://www.ncbi.nlm.nih.gov/pubmed/33037409 http://dx.doi.org/10.1038/s41388-020-01493-8

Ejemplares similares

Novel, non-invasive markers for detecting therapy induced neuroendocrine differentiation in castration-resistant prostate cancer patients
por: Bhagirath, Divya, et al.
Publicado: (2021)

MicroRNA-4287 is a novel tumor suppressor microRNA controlling epithelial-to mesenchymal transition in prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer
por: Akoto, Theresa, et al.
Publicado: (2020)

Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010)

Wnt signaling pathways in urological cancers: past decades and still growing
por: Majid, Shahana, et al.
Publicado: (2012)

MicroRNAs and epithelial-mesenchymal transition in prostate cancer
por: Sekhon, Kirandeep, et al.
Publicado: (2016)

MicroRNA-34a Modulates c-Myc Transcriptional Complexes to Suppress Malignancy in Human Prostate Cancer Cells
por: Yamamura, Soichiro, et al.
Publicado: (2012)

Novel tumor suppressor microRNA at frequently deleted chromosomal region 8p21 regulates Epidermal Growth Factor Receptor in prostate cancer
por: Bucay, Nathan, et al.
Publicado: (2016)

LncRNA CDKN2B-AS1/miR-141/cyclin D network regulates tumor progression and metastasis of renal cell carcinoma
por: Dasgupta, Pritha, et al.
Publicado: (2020)

MicroRNA-383 located in frequently deleted chromosomal locus 8p22 regulates CD44 in prostate cancer
por: Bucay, Nathan, et al.
Publicado: (2016)

Silibinin suppresses bladder cancer through down-regulation of actin cytoskeleton and PI3K/Akt signaling pathways
por: Imai-Sumida, Mitsuho, et al.
Publicado: (2017)

Role of Exosomes in Prostate Cancer Metastasis
por: Akoto, Theresa, et al.
Publicado: (2021)

MicroRNA-23b Functions as a Tumor Suppressor by Regulating Zeb1 in Bladder Cancer
por: Majid, Shahana, et al.
Publicado: (2013)

MicroRNA-466 inhibits tumor growth and bone metastasis in prostate cancer by direct regulation of osteogenic transcription factor RUNX2
por: Colden, Melissa, et al.
Publicado: (2017)

MicroRNA-4723 Inhibits Prostate Cancer Growth through Inactivation of the Abelson Family of Nonreceptor Protein Tyrosine Kinases
por: Arora, Sumit, et al.
Publicado: (2013)

Correction: Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Influence of lifestyle choices on risks of CYP1B1 polymorphisms for prostate cancer
por: Kato, Taku, et al.
Publicado: (2018)

MicroRNA-1280 Inhibits Invasion and Metastasis by Targeting ROCK1 in Bladder Cancer
por: Majid, Shahana, et al.
Publicado: (2012)

Genistein Suppresses Prostate Cancer Growth through Inhibition of Oncogenic MicroRNA-151
por: Chiyomaru, Takeshi, et al.
Publicado: (2012)

Differential expression of miR-34b and androgen receptor pathway regulate prostate cancer aggressiveness between African-Americans and Caucasians
por: Shiina, Marisa, et al.
Publicado: (2016)

The role of miR-24 as a race related genetic factor in prostate cancer
por: Hashimoto, Yutaka, et al.
Publicado: (2017)

Genistein Up-Regulates Tumor Suppressor MicroRNA-574-3p in Prostate Cancer
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

Genistein Inhibits Prostate Cancer Cell Growth by Targeting miR-34a and Oncogenic HOTAIR
por: Chiyomaru, Takeshi, et al.
Publicado: (2013)

Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022)

Inactivation of bone morphogenetic protein 2 may predict clinical outcome and poor overall survival for renal cell carcinoma through epigenetic pathways
por: Mitsui, Yozo, et al.
Publicado: (2015)

Suppressor effect of catechol-O-methyltransferase gene in prostate cancer
por: Hashimoto, Yutaka, et al.
Publicado: (2021)

Inhibition of PTEN Gene Expression by Oncogenic miR-23b-3p in Renal Cancer
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

DNA mismatch repair gene MLH1 induces apoptosis in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2014)

Oncogenic microRNA-4534 regulates PTEN pathway in prostate cancer
por: Nip, Hannah, et al.
Publicado: (2016)

Role of transcription factors and chromatin modifiers in driving lineage reprogramming in treatment-induced neuroendocrine prostate cancer
por: Sreekumar, Amritha, et al.
Publicado: (2023)

Functional role of DNA mismatch repair gene PMS2 in prostate cancer cells
por: Fukuhara, Shinichiro, et al.
Publicado: (2015)

Functional role and tobacco smoking effects on methylation of CYP1A1 gene in prostate cancer
por: Mitsui, Yozo, et al.
Publicado: (2016)

Up-Regulation of MicroRNA-21 Correlates with Lower Kidney Cancer Survival
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Multitarget Molecular Imaging in Metastatic Castration Resistant Adenocarcinoma Prostate Cancer with Therapy Induced Neuroendocrine Differentiation
por: Vargas Ahumada, Joel, et al.
Publicado: (2022)

Prolonged Response to an IGF-1 Receptor Antibody in a Patient with Metastatic Castration Prostate Cancer with Neuroendocrine Differentiation
por: Graff, Julie N, et al.
Publicado: (2015)

Ectopic adrenocorticotrophic hormone syndrome secondary to treatment-related neuroendocrine differentiation of metastatic castrate-resistant prostate cancer
por: Tan, Chelsea, et al.
Publicado: (2022)

Oncogenic miRNA-182-5p Targets Smad4 and RECK in Human Bladder Cancer
por: Hirata, Hiroshi, et al.
Publicado: (2012)

Divergent clonal evolution of castration resistant neuroendocrine prostate cancer
por: Beltran, Himisha, et al.
Publicado: (2016)

Complete metabolic response of metastatic castration‐resistant neuroendocrine carcinoma of the prostate after treatment with RRx‐001 and reintroduced platinum doublets
por: Ojemuyiwa, Michelle, et al.
Publicado: (2018)

Prognostic Evaluation of Metastatic Castration Resistant Prostate Cancer and Neuroendocrine Prostate Cancer with [(68)Ga]Ga DOTATATE PET-CT
por: Bilen, Mehmet Asim, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0dlul3c68ldlb731d145bo1g1q